Kolexia
Villard Orianne
Endocrinologie
Hôpital Lapeyronie
Montpellier, France
50 Activités
185 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Diabète de type 1 Diabète de type 2 Diabète Inflammation COVID-19 Maladie de Basedow Défaillance rénale chronique Hypoglycémie Infection croisée

Industries

Sanofi
14 collaboration(s)
Dernière en 2023
Novo Nordisk
4 collaboration(s)
Dernière en 2023
Ipsen
2 collaboration(s)
Dernière en 2023
Lilly
2 collaboration(s)
Dernière en 2022

Dernières activités

Effects of hypoglycaemic agents on reducing surrogate metabolic parameters for the prevention of cardiovascular events and death in patients with type 2 diabetes: A systematic review and meta-analysis.
Diabetes, obesity & metabolism   23 octobre 2023
Safety and Efficacy of Sustained Automated Insulin Delivery Compared With Sensor and Pump Therapy in Adults With Type 1 Diabetes at High Risk for Hypoglycemia: A Randomized Controlled Trial.
Diabetes care   20 septembre 2023
Assessment of Meal Anticipation for Improving Fully Automated Insulin Delivery in Adults With Type 1 Diabetes.
Diabetes care   28 août 2023
Under-Representation of Diverse Populations and Glycemic Outcomes in Major Clinical Trials of Automated Insulin Delivery.
Diabetes technology & therapeutics   11 juillet 2023
Psychological care of patients during the pancreas transplantation process: issues and prospects.
Frontiers in clinical diabetes and healthcare   10 juillet 2023
Efficacité du tocilizumab sur le myxœdème pré-tibial sévère dans la maladie de Basedow
Annales d'endocrinologie   01 février 2023
Evaluation of Accuracy of Continuous Glucose Monitoring (CGM) in Patients With End Stage Renal Disease (ESRD) on Intermittent Hemodialysis (iHD).
Essai Clinique (DexCom, Inc.)   29 novembre 2022
Accuracy of a Factory-Calibrated Continuous Glucose Monitor in Individuals With Diabetes on Hemodialysis.
Diabetes care   11 juillet 2022
The nuclear receptor REV-ERBα is implicated in the alteration of β-cell autophagy and survival under diabetogenic conditions.
Cell death & disease   15 avril 2022
Increased risks of SARS-CoV-2 nosocomial acquisition in high-risk COVID-19 units justify personal protective equipment: a cross-sectional study.
The Journal of hospital infection   01 novembre 2020